Literature DB >> 23681608

Moving from basic toward systems pharmacodynamic models.

William J Jusko1.   

Abstract

Building upon many classical foundations of pharmacology, a diverse array of mechanistic pharmacokinetic-pharmacodynamic (PK/PD) models have emerged based on mechanisms of drug action and primary rate-limiting or turnover processes in physiology. An array of basic models can be extended to handle various complexities including tolerance and can readily be employed as building blocks in assembling enhanced PK/PD or small systems models. Our corticosteroid models demonstrate these concepts as well as elements of horizontal and vertical integration of molecular to whole-body processes. The potential advantages and challenges in moving PK/PD toward systems models are described.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  dose response; indirect response models; mathematical model; pharmacodynamics; pharmacokinetics; pharmacometrics; preclinical pharmacokinetics; systems pharmacology

Mesh:

Year:  2013        PMID: 23681608      PMCID: PMC3743951          DOI: 10.1002/jps.23590

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  47 in total

1.  General pharmacokinetic model for drugs exhibiting target-mediated drug disposition.

Authors:  D E Mager; W J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2001-12       Impact factor: 2.745

2.  Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.

Authors:  A Sharma; W F Ebling; W J Jusko
Journal:  J Pharm Sci       Date:  1998-12       Impact factor: 3.534

3.  In silico experiments of existing and hypothetical cytokine-directed clinical trials using agent-based modeling.

Authors:  Gary An
Journal:  Crit Care Med       Date:  2004-10       Impact factor: 7.598

4.  Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics.

Authors:  Y N Sun; W J Jusko
Journal:  J Pharm Sci       Date:  1998-06       Impact factor: 3.534

Review 5.  Merging systems biology with pharmacodynamics.

Authors:  Ravi Iyengar; Shan Zhao; Seung-Wook Chung; Donald E Mager; James M Gallo
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

6.  Pharmacodynamics of chemotherapeutic effects: dose-time-response relationships for phase-nonspecific agents.

Authors:  W J Jusko
Journal:  J Pharm Sci       Date:  1971-06       Impact factor: 3.534

7.  Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.

Authors:  J G Wagner
Journal:  J Theor Biol       Date:  1968-08       Impact factor: 2.691

8.  Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.

Authors:  Amit Garg; Joseph P Balthasar
Journal:  J Pharmacokinet Pharmacodyn       Date:  2007-07-18       Impact factor: 2.745

9.  Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.

Authors:  Rohini Ramakrishnan; Debra C DuBois; Richard R Almon; Nancy A Pyszczynski; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2002-02       Impact factor: 2.745

10.  NIH Support for the Emergence of Quantitative and Systems Pharmacology.

Authors:  M Rogers; P Lyster; R Okita
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-10
View more
  31 in total

Review 1.  Pharmacokinetic and pharmacodynamic considerations for the next generation protein therapeutics.

Authors:  Dhaval K Shah
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-09-15       Impact factor: 2.745

2.  Stochastic process pharmacodynamics: dose timing in neonatal gentamicin therapy as an example.

Authors:  Tomas Radivoyevitch; Nopphon Siranart; Lynn Hlatky; Rainer Sachs
Journal:  AAPS J       Date:  2015-02-07       Impact factor: 4.009

3.  Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.

Authors:  Vivaswath S Ayyar; Siddharth Sukumaran; Debra C DuBois; Richard R Almon; Jun Qu; William J Jusko
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-04-27       Impact factor: 2.745

4.  Integrated Multi-stakeholder Systems Thinking Strategy: Decision-making with Biopharmaceutics Risk Assessment Roadmap (BioRAM) to Optimize Clinical Performance of Drug Products.

Authors:  Arzu Selen; Anette Müllertz; Filippos Kesisoglou; Rodney J Y Ho; Jack A Cook; Paul A Dickinson; Talia Flanagan
Journal:  AAPS J       Date:  2020-07-27       Impact factor: 4.009

5.  Functional proteomic analysis of corticosteroid pharmacodynamics in rat liver: Relationship to hepatic stress, signaling, energy regulation, and drug metabolism.

Authors:  Vivaswath S Ayyar; Richard R Almon; Debra C DuBois; Siddharth Sukumaran; Jun Qu; William J Jusko
Journal:  J Proteomics       Date:  2017-03-14       Impact factor: 4.044

Review 6.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

7.  On the analysis of complex biological supply chains: From Process Systems Engineering to Quantitative Systems Pharmacology.

Authors:  Rohit T Rao; Megerle L Scherholz; Clara Hartmanshenn; Seul-A Bae; Ioannis P Androulakis
Journal:  Comput Chem Eng       Date:  2017-06-03       Impact factor: 3.845

8.  Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.

Authors:  Vivaswath S Ayyar; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  J Pharmacol Exp Ther       Date:  2017-07-20       Impact factor: 4.030

9.  Quantitative Systems Pharmacology: A Framework for Context.

Authors:  Ioannis P Androulakis
Journal:  Curr Pharmacol Rep       Date:  2016-04-08

Review 10.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.